Dublin, April 29, 2025 (GLOBE NEWSWIRE) -- The "Spain Continuous Glucose Monitoring Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.
Spain's continuous glucose monitoring market to surpass US$114.025 million by 2030, growing at a 10.39% CAGR from US$69.552 million in 2025.
The Spanish CGM market is booming due to the strong prevalence of diabetes and a huge focus on glycemic control. Technological advancements, like smaller sensors and longer wear times, are also improving patient experience and driving market expansion.
For instance, in February 2024, Dexcom, Inc. launched its new CGM system, Dexcom ONE+, for people with diabetes worldwide. In some countries, Dexcom ONE+ supersedes the previous generation Dexcom ONE sensor.
Market Trends:
- Increasing diabetes prevalence driving CGM adoption in Spain: The growing number of diabetes cases in Spain is fueling the demand for effective diabetes management solutions. Continuous Glucose Monitoring (CGM) devices provide critical insights into blood glucose levels, helping patients and healthcare professionals make informed decisions about diet, physical activity, and medication.
- Significant growth in the male CGM market in Spain: The CGM market for males in Spain is expanding rapidly, driven by factors such as the high prevalence of diabetes, particularly type 2. CGM devices play a crucial role in managing blood sugar levels by offering real-time data, benefiting both patients and healthcare providers.
- Rising demand among adults aged 20 and older: The CGM market for adults aged 20 and above in Spain is experiencing substantial growth, primarily due to the increasing prevalence of diabetes, especially type 2, within this age group. CGM devices are essential for effective blood sugar management, reducing the risk of diabetes-related complications. By 2030, it is estimated that 11.8% of Spaniards aged 20 and older will have diabetes, further driving the demand for CGM technology.
Some of the major players covered in this report include Dexcom, Inc., Abbott Laboratories, Medtronic, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, Inc., DiaMonTech AG, among others.
Report Coverage:
- Historical data from 2022 to 2024 & forecast data from 2025 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Companies Featured
- Dexcom, Inc.
- Abbott Laboratories
- Medtronic
- F. Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- DiaMonTech AG
- A. Menarini Diagnostics
- Insulcloud S.L.
- YPSOMED
- Diabeloop SA
- MicroTech Medical, Inc
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 105 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $69.55 Million |
| Forecasted Market Value (USD) by 2030 | $114.03 Million |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Spain |
The Spain continuous glucose monitoring Market is analyzed into the following segments:
By Type
- Real-Time CGM
- Intermittently CGM
By Gender
- Male
- Female
By Age
- Greater than 20
- Less than 20
By Application
- Diabetes Patients
- Critical Patients
By End-User
- Hospitals
- Diagnostic Center and Clinics
- Home Care
For more information about this report visit https://www.researchandmarkets.com/r/amlp6l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
